The US Food and Drug Administration confirmed via “Twitter” that it and the Centers for Disease Control and Prevention “are evaluating the potential importance of 6 cases that were recorded of rare blood clots of its kind in people who received the vaccine.”
She stated, “We recommend a freeze until this process is completed.”
The six reported cases were among more than 6.8 million doses of the Johnson & Johnson vaccine administered in the United States.
All six cases occurred in women between the ages of 18 and 48, and symptoms appeared 6 to 13 days after vaccination, according to a joint statement by the First Deputy Director of the CDC, Dr. Ann Schuchat, and the Director of the Center for Biological Assessment and Research at the Food and Drug Administration, Dr. Peter Marks.
The statement said the CDC will hold a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to continue reviewing these cases and assess their potential significance.
The Food and Drug Administration will also review this analysis because it is also investigating these cases.
Until this process is complete, the two administrations have recommended that this vaccine be discontinued out of great caution.
And on Friday, the European Medicines Regulatory Authority announced that it is studying cases of blood clots after taking it Johnson & Johnson vaccine.
“France-Presse” said that the announcement by the European Medicines Regulatory Authority comes after 4 cases of blood clots were recorded, including one death.
The authority stated that its safety committee “began studying reports to verify cases of blood clots after taking the vaccine.”
She added that 3 cases were recorded in the United States and the fourth during clinical trials at an unspecified location.